Tuesday , November 21 2017
Home / Specialties / Pediatrics / Silva A. Arslanian, MD: How does the drug approval process differ for children?

Silva A. Arslanian, MD: How does the drug approval process differ for children?

Silva-ArslanianSilva A. Arslanian, MD, explains the rigorous process for gaining approval for new diabetes drugs for children, and points out that the type 2 rate is not yet at epidemic proportions in children (as it is in adults)….

 

 

 

More videos with Dr. Arslanian:

Silva A. Arslanian, MD, Introduction

T2DM in Children – Earlier co-morbidities?

What drugs can be prescribed to children with diabetes?

Disparities in diabetes rates between children of different socio-economic class

Difficulties of Educating Parents

Silva A. Arslanian, MD, is Chief, Weight Management and Wellness Center; Director, Pediatric Clinical and Translational Research Center; UPMC Richard L. Day Endowed Chair in Pediatrics; and Professor of Pediatrics, University of Pittsburgh School of Medicine. She attended medical school at the American University of Beirut School of Medicine, Beirut, Lebanon; did her residency at the American University Hospital of Beirut, Beirut, Lebanon; and fellowship at Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.